Mastodon

Ecdisten (Tablets) Instructions for Use

ATC Code

A14B (Other anabolic preparations)

Clinical-Pharmacological Group

Herbal preparation with general tonic effect

Pharmacotherapeutic Group

Metabolic agent

Pharmacological Action

A natural compound of steroid structure from the roots and rhizomes of Rhaponticum carthamoides; has a tonic effect, promotes the enhancement of protein synthesis processes in the body. Increases mental and physical performance.

Indications

  • Asthenic syndrome associated with weakening of protein-synthesizing processes;
  • During prolonged intoxications, infections;
  • Mental and physical fatigue;
  • In athletes, as a medicinal product that increases speed-strength qualities during the preparation period for competitions.

ICD codes

ICD-10 code Indication
F48.0 Neurasthenia
Z54 Convalescence
Z73.0 Burn-out
Z73.3 Stress, not elsewhere classified (physical and mental strain)
ICD-11 code Indication
6A8Z Affective disorders, unspecified
QB7Z Convalescence, unspecified
QD85 Burn-out
QE01 Stress, not elsewhere classified

Dosage Regimen

The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen.

Take tablets orally, after meals.

For general use, take 1-2 tablets (0.005-0.01 g) three times daily.

The standard treatment course is 15-20 days.

A repeat course is possible after a 1-2 week interval, upon physician recommendation.

In sports medicine, for athletic preparation, take 2 tablets (0.01 g) three times daily.

The duration of use in sports medicine is 2-3 weeks.

Do not exceed the maximum single dose of 2 tablets (0.01 g).

Do not exceed the maximum daily dose of 6 tablets (0.03 g).

Adverse Reactions

Insomnia, increased blood pressure, pain in the epigastric region are possible.

If any of the side effects listed in the instructions get worse, or you notice any other side effects not listed in the instructions, tell your doctor.

Contraindications

  • Nervous excitement;
  • Insomnia;
  • Arterial hypertension;
  • Epilepsy;
  • Hyperkinesis;
  • Gastric and duodenal ulcer (in the acute stage);
  • Congenital fructose intolerance;
  • Glucose-galactose malabsorption;
  • Sucrase/isomaltase deficiency;
  • Pregnancy;
  • Lactation period;
  • Age under 18 years;
  • Increased individual sensitivity to the components of the drug.

If you have one of the listed diseases, be sure to consult your doctor before taking the drug.

With caution in patients with diabetes mellitus and persons on a diet with reduced carbohydrate content.

Use in Pregnancy and Lactation

The drug is contraindicated during pregnancy and lactation.

Pediatric Use

Contraindicated in children under 18 years of age.

Special Precautions

To achieve the effect, along with the use of the drug, it is necessary to receive adequate amounts of proteins, fats, carbohydrates, vitamins, and minerals with food.

In case of adverse reactions, including to avoid sleep disturbances, it is advisable to reduce the dose or discontinue the evening dose of the drug.

Patients with diabetes mellitus should take into account that one tablet of the drug contains about 0.094 g of carbohydrates (0.008 XE).

Effect on ability to drive vehicles and mechanisms

The use of the drug does not affect the ability to drive vehicles and engage in other potentially hazardous activities that require increased concentration and speed of psychomotor reactions.

Overdose

Symptoms: possible intensification of dose-dependent adverse reactions.

Treatment: symptomatic.

Drug Interactions

With simultaneous use, it is possible to enhance the effect of stimulants and analeptics (caffeine, camphor, phenamine).

The drug is an antagonist of drugs that depress the central nervous system (including neuroleptics, barbiturates, tranquilizers, anticonvulsants).

Storage Conditions

The drug should be stored out of the reach of children at a temperature not exceeding 25°C (77°F).

Shelf Life

Shelf life is 4 years.

Do not use after the expiration date.

Dispensing Status

The drug is dispensed without a prescription.

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.

Medical Disclaimer

Brand (or Active Substance), Marketing Authorisation Holder, Dosage Form

Marketing Authorization Holder

Vifitech, CJSC (Russia)

Dosage Form

Bottle OTC Icon Ecdysten Tablets 5 mg: 30 or 50 pcs.

Dosage Form, Packaging, and Composition

Tablets round, flat-cylindrical in shape with a bevel, from white to white with a yellowish tint.

1 tab.
Ecdysten* 5 mg

* calculated as 100% substance.

Excipients: sucrose – 89 mg, potato starch – 5 mg, calcium stearate – 1 mg.

10 pcs. – contour cell packs (3) – cardboard packs.
10 pcs. – contour cell packs (5) – cardboard packs.
15 pcs. – contour cell packs (2) – cardboard packs.
30 pcs. – contour cell packs (1) – cardboard packs.

.

Marketing Authorization Holder

Aspen Pharma, Pty. Ltd. (India)

Manufactured By

Vifitech, CJSC (Russia)

Dosage Form

Bottle OTC Icon Ecdisten tablets 0.005 g Tablets 5 mg: 30 pcs.

Dosage Form, Packaging, and Composition

Tablets 1 tab.
Ecdysten 0.005 g

30 pcs. – contour cell packs (1) – cardboard packs.
30 pcs. – dark glass jars (1) – cardboard packs.

TABLE OF CONTENTS